Table 1.
Compd. | R1 | R2 | *Selected concentration (μM) |
---|---|---|---|
1 | 4-OMe | 4-OMe | 10 |
3 | 4-OMe | 2,4-OMe | 25 |
5 | 4-OMe | 3,4,5-OMe | 1 |
6 | 5-OMe | 2-OMe | 1 |
7 | 5-OMe | 3-OMe | 10 |
8 | 5-OMe | 4-OMe | 10 |
9 | 5-OMe | 2,4-OMe | 25 |
10 | 5-OMe | 3,4,5-OMe | 1 |
11 | 5-OMe | 2, 6-OMe | 1 |
12 | 7-OMe | 2, 4-OMe | 10 |
13 | 4-OH | 4-OH | 25 |
15 | 4-OH | 2,4-OH | 25 |
16 | 4-OH | 3,4,5-OH | 25 |
17 | 5-OH | 2-OH | 25 |
18 | 5-OH | 3-OH | 25 |
19 | 5-OH | 4-OH | 25 |
20 | 5-OH | 2,4-OH | 25 |
21 | 5-OH | 3,4,5-OH | 25 |
22 | 5-OH | 2,6-OH | 10 |
23 | 7-OH | 2,4-OH | 10 |
24 | / | / | 10 |
The concentrations that did not decrease the viability of NCI-H460 and NCI-H460/MX20 cells by more than 20%.